Relationship Between Prenatal Maternal Distress and the Quality of General Movements at 3 Months
NCT ID: NCT05694676
Last Updated: 2023-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2023-02-17
2023-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Such maladaptive outcomes are thought to have a neurobiological basis and there is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. However, what is more important is that the neurological footprints of these structural changes on the young brain can be caught early in life. The neurological status of infants can be determined early in life by video assessment of General Movements (GMs) quality. In this study at the age of 3 months, a video assessment of the quality of GMs will be performed to evaluate neurologic conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mothers
Mothers aged 18 to 40 years, who have singleton pregnancy.
State-Trait Anxiety Inventory-Trait, (STAI-T)
The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
Beck Depression Inventory, (BDI)
BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression
Infants
Infants were born at 36-42 weeks of gestation without complication.
Assessment of the quality of Genaral Movements (GMs)
The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of the quality of Genaral Movements (GMs)
The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
State-Trait Anxiety Inventory-Trait, (STAI-T)
The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
Beck Depression Inventory, (BDI)
BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy
* No smoking during prengnancy
* No illicit drug or alcohol use during pregnancy,
* No major health conditions requiring invasive treatments (e.g., dialysis, blood transfusions, chemotherapy),
* No diagnosis of psychotic illnesses (eg, schizophrenia,bipolar or borderline personality disorder), and
* No major autoimmune diseases
* No pregnancy-related complications: (including prenatal infection, pregnancy-included hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm labor, vaginal bleeding, placenta previa, or anemia).
Infant inclusionary criteria:
* infants were born at 36-42 wk of gestation
* uncomplicated singleton birth,
* no pre-existing neurologic conditions or major head trauma, neonatal intensive care unit stay limited to observation only (ie, no interventions), and
* infant discharged from the hospital with the mother.
Exclusion Criteria
* delivery complication
Infant exclusion criteri:
* infant birth before 36 weeks gestation
* infant weight lower 2500gr at birth
* Apgar score 0f \<7 at 5 minutes
* Major neonatal complications
* Identified neurologic, genetic or congenital syndrome
10 Weeks
20 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karaman Training and Research Hospital
OTHER
Karamanoğlu Mehmetbey University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aynur Başaran
MD, Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aynur Basaran, MD,Prof
Role: STUDY_DIRECTOR
Karaman Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karaman Training and Research Hospital
Karaman, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-2022/02
Identifier Type: -
Identifier Source: org_study_id